SUANFARMA, S.A. engages in the development, manufacture, and distribution of raw materials and finished dosage forms for pharmaceutical, biotechnological, veterinary, nutritional, and cosmetic sectors. The company offers generics and active pharmaceutical ingredients, such as anti-infective, cardiovascular system, central nervous system, digestive system, endocrine system, oncology, respiratory system, and pain and inflammation products; and food supplements, and medicinal and dietary plants, including non-native vegetable species, dietary supplements, plant extracts, jellies, syrups, oligotherapy, litotherapy, etc. It also provides active ingredients for veterinary industry, such as antibiotics, NSAIDs, antiparasitics, glucocorticoids, nutritional, reproduction, and others; and develops alternative routes of synthesis for obtaining active pharmaceutical ingredients and their subsequent industrial scale-up. In addition, the company invests in seed and early-stage biotechnology companies; delivers its expertise to biotech companies on issues related to business and commercial management; and provides support on scientific, industrial, regulatory, and financial development. It serves customers in Spain and internationally. The company was founded in 1993 and is based in Alcobendas, Spain. It has locations in Phoenix, Arizona; Fair Lawn, New Jersey; Naucalpan de Juárez, Mexico; Bogotá, Colombia; Caracas, Venezuela; Sao Paulo, Brazil; Buenos Aires, Argentina; Santiago, Chile; Madrid and Barcelona, Spain; Fitbourg, Switzerland; Dubai, United Arab Emirates; Navi Mumbai, India; and Shanghai, China.